GoodRx Holdings, Inc. (NASDAQ:GDRX) Q2 2022 Earnings Conference Call August 8, 2022 5:00 PM ET

Company Participants

Whitney Notaro - Vice President-Investor Relations

Doug Hirsch - Co-Founders & Co-Chief Executive Officer

Trevor Bezdek - Co-Founders & Co-Chief Executive Officer

Karsten Voermann - Chief Financial Officer

Conference Call Participants

Glen Santangelo - Jefferies

Sandy Draper - Guggenheim Partners

Stephanie Davis - SVB Securities

Michael Cherny - BofA

Craig Hettenbach - Morgan Stanley

Mark Mahaney - Evercore ISI

Eric Sheridan - Goldman Sachs

Doug Anmuth - JPMorgan

Charles Rhyee - Cowen

John Ransom - Raymond James

George Hill - Deutsche Bank

Stan Berenshteyn - Wells Fargo

Steven Valiquette - Barclays

Jonathan Yong - Credit Suisse

Operator

Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Second Quarter 2022 Earnings Call. As a reminder, today's conference call is being recorded.

I would now like to introduce your host for today's call, Whitney Notaro, Vice President of Investor Relations. Ms. Notaro, you may begin. .

Whitney Notaro

Thank you, operator. Good afternoon, everyone, and welcome to GoodRx's earnings conference call for the second quarter of 2022. Joining me today are Doug Hirsch and Trevor Bezdek, our Co-Founders and Co-Chief Executive Officer; and Karsten Voermann, our Chief Financial Officer.

Before we begin, I'd like to remind everyone that this call will contain forward-looking statements. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding management's plans, strategies, goals and objectives, our market opportunity, our anticipated financial performance, the impact of the grocer issue on our business and the expected impact of COVID-19 on our business.

These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors. These factors may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

Factors discussed in the Risk Factors section of our annual report on Form 10-K for the year ended December 31, 2021, as updated by our quarterly report on Form 10-Q for the quarter ended June 30, 2022, and our other filings with the Securities and Exchange Commission could cause actual results to differ materially from those indicated by the forward-looking statements made on this call.

Any such forward-looking statements represent management's estimates as of the date of this call, and we disclaim any obligation to update these statements, even if subsequent events cause our views to change.